What does CUSIP 03237H101 represent in this 13F holders report?

CUSIP 03237H101 is the security identifier for AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock in Q2 2023?

153 institutional investors reported AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX)

CUSIP: 03237H101

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock
Shares outstanding: 109,540,561
Total 13F shares: 54,545,075
Share change: +3,184,647
Total reported value: $1,176,653,052
Put/Call ratio: 32%
Price per share: $21.57
Number of holders: 153
Value change: +$56,163,167
Number of buys: 95
Number of sells: 63

Quarterly Holders Quick Answers

What is CUSIP 03237H101?
CUSIP 03237H101 identifies AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 03237H101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PERCEPTIVE ADVISORS LLC	13F	Company	5.5%	6,034,644	$177,056,455	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	4.3%	4,747,341	$139,286,986	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	3.3%	3,614,918	$106,061,695	—	31 Mar 2023	13F
ALS Invest 1 B.V.	3/4/5	10%+ Owner	— class O/S missing	5,895,280	$96,258,721	—	06 Jul 2022	3/4/5
VIKING GLOBAL INVESTORS LP	13F 3/4/5	Company · 10%+ Owner	2.7%	2,962,555	$86,921,364	—	31 Mar 2023	13F 3/4/5
Boxer Capital, LLC	13F	Company	1.9%	2,084,000	$61,145,000	—	31 Mar 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	1.8%	2,022,370	$59,336,336	—	31 Mar 2023	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	1.8%	1,984,333	$58,220,330	—	31 Mar 2023	13F
FEDERATED HERMES, INC.	13F	Company	1.7%	1,846,117	$54,165,073	—	31 Mar 2023	13F
Rock Springs Capital Management LP	13F	Company	1.3%	1,452,816	$42,625,621	—	31 Mar 2023	13F
PICTET ASSET MANAGEMENT SA	13F	Company	1.3%	1,433,846	$42,069,042	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.2%	1,366,172	$40,083,487	—	31 Mar 2023	13F
DRAGSA 96 LLC	3/4/5	10%+ Owner	— class O/S missing	2,300,000	$37,554,630	—	11 Jan 2022	3/4/5
MARSHALL WACE, LLP	13F	Company	1%	1,139,240	$33,425,302	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.98%	1,074,610	$31,529,000	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.97%	1,066,238	$31,283,423	—	31 Mar 2023	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.92%	1,007,336	$29,555,238	—	31 Mar 2023	13F
EMERALD ADVISERS, LLC	13F	Company	0.89%	972,835	$28,542,979	—	31 Mar 2023	13F
Alpha Wave Global, LP	13F	Company	0.85%	930,337	$27,296,088	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.82%	902,547	$26,480,729	—	31 Mar 2023	13F
Avidity Partners Management LP	13F	Company	0.82%	900,000	$26,406,000	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.81%	890,982	$26,141,422	—	31 Mar 2023	13F
ORBIMED ADVISORS LLC	13F	Company	0.74%	813,500	$23,868,090	—	31 Mar 2023	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.72%	789,591	$23,166,600	—	31 Mar 2023	13F
GREAT POINT PARTNERS LLC	13F	Company	0.72%	783,795	$22,996,545	—	31 Mar 2023	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.57%	619,030	$18,162,340	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.56%	611,932	$17,954,000	—	31 Mar 2023	13F
Ghost Tree Capital, LLC	13F	Company	0.43%	475,000	$13,937,000	—	31 Mar 2023	13F
Avoro Capital Advisors LLC	13F	Company	0.43%	473,100	$13,880,754	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.42%	463,880	$13,610,240	—	31 Mar 2023	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.42%	458,054	$13,439,304	—	31 Mar 2023	13F
Woodline Partners LP	13F	Company	0.4%	434,200	$12,739,428	—	31 Mar 2023	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.38%	420,841	$12,347,475	—	31 Mar 2023	13F
ExodusPoint Capital Management, LP	13F	Company	0.36%	393,904	$11,557,000	—	31 Mar 2023	13F
Point72 Asset Management, L.P.	13F	Company	0.3%	324,800	$9,529,632	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.29%	320,086	$9,391,323	—	31 Mar 2023	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.26%	285,005	$8,362,046	—	31 Mar 2023	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.25%	277,788	$8,150,299	—	31 Mar 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.24%	264,858	$7,770,934	—	31 Mar 2023	13F
Alyeska Investment Group, L.P.	13F	Company	0.23%	251,407	$7,376,281	—	31 Mar 2023	13F
LORD, ABBETT & CO. LLC	13F	Company	0.23%	250,042	$7,336,000	—	31 Mar 2023	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.22%	242,400	$7,112,016	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.21%	228,906	$6,716,102	—	31 Mar 2023	13F
Verition Fund Management LLC	13F	Company	0.2%	221,598	$6,501,685	—	31 Mar 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.19%	212,453	$6,233,371	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.19%	204,656	$6,004,607	—	31 Mar 2023	13F
Altium Capital Management LLC	13F	Company	0.17%	185,000	$5,427,900	—	31 Mar 2023	13F
Polar Asset Management Partners Inc.	13F	Company	0.16%	177,200	$5,199,048	—	31 Mar 2023	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.12%	135,465	$3,974,543	—	31 Mar 2023	13F
TWINBEECH CAPITAL LP	13F	Company	0.12%	131,772	$3,866,190	—	31 Mar 2023	13F

Institutional Holders of Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX) as of Q2 2023

As of 30 Jun 2023, Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX) was held by 153 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,545,075 shares. The largest 10 holders included VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., VIKING GLOBAL INVESTORS LP, Boxer Capital, LLC, MARSHALL WACE, LLP, MILLENNIUM MANAGEMENT LLC, D. E. Shaw & Co., Inc., Rock Springs Capital Management LP, and FEDERATED HERMES, INC.. This page lists 153 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

145

Q2 2023 holders

153

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.